Article
The von Hippel–Lindau tumor suppressor gene is required for cell cycle exit upon serum withdrawal
3 Feb 1998
Abstract excerpt
The inactivation of the von Hippel-Lindau (VHL) tumor suppressor gene predisposes affected individuals to the human VHL cancer syndrome and is associated with sporadic renal cell carcinomas (RCC) and brain hemangioblastomas. VHL-negative 786-0 RCC cells are tumorigenic in nude mice which is suppressed by the reintroduction of VHL. Remarkably, this occurs without affecting the growth rate and cell cycle profile of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
